Flputnam Investment Management Co. Takes $1.66 Million Position in Phreesia, Inc. $PHR

Flputnam Investment Management Co. bought a new position in shares of Phreesia, Inc. (NYSE:PHR) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 160,903 shares of the company’s stock, valued at approximately $1,656,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Pale Fire Capital SE purchased a new position in Phreesia in the 1st quarter valued at approximately $72,481,000. BlackRock Inc. purchased a new stake in shares of Phreesia during the second quarter worth $72,234,000. Granahan Investment Management LLC raised its stake in shares of Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after acquiring an additional 1,018,987 shares in the last quarter. Prosight Management LP acquired a new stake in shares of Phreesia in the fourth quarter valued at $16,533,000. Finally, Millennium Management LLC boosted its holdings in Phreesia by 730.7% in the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock valued at $25,028,000 after purchasing an additional 936,033 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Performance

NYSE:PHR opened at $12.17 on Monday. Phreesia, Inc. has a 12 month low of $7.77 and a 12 month high of $32.74. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $752.23 million, a PE ratio of 81.13 and a beta of 0.85. The business’s fifty day moving average price is $11.03 and its 200 day moving average price is $10.48.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Truist Financial upped their price target on Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a report on Thursday, May 28th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $9.00 price objective (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Weiss Ratings raised Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, July 20th. Citigroup restated a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Finally, DA Davidson reiterated a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research note on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Phreesia presently has an average rating of “Hold” and a consensus price target of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.